‘Do you have experience with switching to a biosimilar medication?
If so, we are looking to hear from you. Bloodwise is working with IQVIA to gather insights from our blood cancer community about their experiences when switching to a biosimilar medication – any concerns they had, and what was (or would have been) helpful. These insights will help us make recommendations to NHS England and make a real impact on blood cancer patient care. Take a look at the survey here.’